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he protective antigen (PA) of anthrax toxin binds to a
cell surface receptor, undergoes heptamerization,
and binds the enzymatic subunits, the lethal factor
(LF) and the edema factor (EF). The resulting complex is
then endocytosed. Via mechanisms that depend on the
vacuolar ATPase and require membrane insertion of PA, LF
and EF are ultimately delivered to the cytoplasm where
T
 
their targets reside. Here, we show that membrane insertion
of PA already occurs in early endosomes, possibly only in
the multivesicular regions, but that subsequent delivery of
LF to the cytoplasm occurs preferentially later in the endocytic
pathway and relies on the dynamics of internal vesicles of
multivesicular late endosomes.
 
Introduction
 
Anthrax toxin, one of the two main virulence factors pro-
duced by 
 
Bacillus anthracis
 
, is an A-B type toxin, where the
B subunit, called the protective antigen (PA), is involved in
cell binding and the A subunits, of which there are two, lethal
factor (LF) and edema factor (EF), bare the enzymatic toxic
activities (Collier and Young, 2003). LF, a metalloprotease
that targets MAPK kinases (MAPKKs), is responsible for
lethality of the toxin (Collier and Young, 2003). EF, a CaM-
dependent adenylate cyclase that elevates intracellular levels
of cAMP (Collier and Young, 2003), is responsible for edema
observed in anthrax patients.
PA (83 kD) binds to one of the two identified anthrax
toxin receptors, ANTXR1 and ANTXR2 (Collier and Young,
2003), and is then processed at the NH
 
2
 
 terminus by the en-
doprotease furin, leaving a 63-kD form bound to the recep-
tor. PA63 subsequently heptamerizes giving rise to a complex
(PA
 
heptamer
 
) that is able to bind up to three molecules of LF
and/or EF (Collier and Young, 2003). Heptamerization is ac-
companied by a spatial redistribution of the receptor from
the glycerophospholipid region of the plasma membrane to
specialized microdomains, so-called lipid rafts (Abrami et
al., 2003). This redistribution triggers endocytosis of the
PA
 
heptamer
 
–EF/LF complex (Abrami et al., 2003). Upon en-
counter of a sufficiently acidic milieu, PA
 
heptamer
 
 undergoes a
conformational change that leads to membrane insertion,
which allows translocation of LF/EF across the endosomal
membrane and delivery to the cytoplasm (Collier and Young,
2003). It is not clear at which stations of the endocytic path-
way membrane insertion of PA
 
heptamer
 
, translocation of the
enzymatic units, and their release into the cytoplasm occur.
Here, we show that membrane insertion of PA
 
heptamer
 
 can be
uncoupled from cytoplasmic delivery of LF, each occurring at
different stages of the endocytic pathway.
 
Results and discussion
 
We have previously shown that upon heptamerization,
PA
 
heptamer
 
 is internalized, transported to early endosomes,
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and then rapidly degraded (Abrami et al., 2003) indicating
efficient transport to lysosomes and exclusion from the recy-
cling pathway. Here, we investigated whether PA
 
heptamer
 
 un-
dergoes pH-induced membrane insertion in early or in late
endosomes. Early and late endosomes were isolated from
toxin-treated BHK cells using a well-established subcellular
fractionation protocol (Aniento et al., 1993; Gruenberg,
2001). The SDS-resistant PA
 
heptamer
 
, which only forms after
the pH-dependent conformational change, was highly en-
riched in early endosomes (Fig. 1 A), co-fractionating with
the small GTPase rab5 (Gruenberg, 2001), indicating that
membrane insertion already occurred in early endosomes. In
contrast, little SDS-resistant PA
 
heptamer
 
 was detected in late
endosomes containing rab7, presumably because degrada-
tion is extremely rapid (Abrami et al., 2003). Interestingly,
LF was abundant in early endosomes and clearly detectable
in late endosomes (Fig. 1 A).
The presence of LF in late endosomes and the fact that in-
hibitors of the vacuolar ATPase can delay the death of
macrophages even when added long after LF (Menard et
al., 1996) prompted us to investigate whether transport to
late endocytic compartments was required for intoxication.
Transport from early to late endosomes occurs via multive-
sicular intermediates, here after designated as endosomal
carrier vesicles/multivesicular bodies (ECV/MVB), which
detach from early endosomes and move toward late endo-
somes on microtubules (Gruenberg, 2001; see Fig. 5 for a
schematic view of the endocytic pathway). To this end, we
Figure 1. Conversion of PAheptamer to 
an SDS-resistant form occurs in early 
endosomes and is COPI dependent. 
(A) BHK cells were incubated at 4C, 1 h 
with 500 ng/ml trypsin-nicked PA (PAn; 
Abrami et al., 2003) and 20 ng/ml LF, 
transferred to a toxin-free medium 
(37C,1 h) and treated with 5 U/ml 
trypsin,10 min 37C, to remove surface-
bound toxin. Subcellular fractionation 
of postnuclear supernatants (PNS) was 
performed to separate early (EE) from 
late endosomes (LE) and heavy mem-
branes (HM). 15 g of protein from each 
fraction were analyzed by Western blot-
ting for the presence of PA and PAheptamer, 
LF, rab5, and rab7. (B–D) LdlF cells were 
grown at the permissive (34C) or restric-
tive temperature (40C) for 18 h. (B) 
Cells were incubated for 20 min at 4C 
with 500 ng/ml PASNKE, a PA variant with 
a mutated furin cleavage site, submitted 
to antibody cross-linking at 4C and 
further incubated at 37C for 30 min. 
Surface-bound toxin was removed by 
an acid wash (which lead to the observed 
background staining). Bar, 10 m. (C) 
Cells were incubated with 500 ng/ml 
PAn, 1 h 4C, washed and incubated at 
4C or 37C with a toxin-free medium 
for 15 min. Surface toxin was removed 
as in A. 40 g of PNS was analyzed by 
a SDS-PAGE gel followed by Western 
blotting against PA. (D) ldlF CHO cells 
were incubated at 4C for 1 h with 500 
ng/ml PAn and 500 ng/ml LF, transferred 
to 37C for different periods of time 
(in min) in a toxin-free medium. 40 g 
of total cell extracts were analyzed by 
Western blotting to detect LF processed 
MEK1 (anti–NH2-terminal antibody), 
total MEK1 (anti–COOH-terminal anti-
body), LF, ε-COP, and PA. (E–J) BHK 
cells were incubated with 10 g/ml PAn 
for 1 h at 4C, warmed to 37C for either 
10 min (E) or 40 min (F–J) before fixation 
and preparation of ultrathin sections. 
Sections were labeled with rabbit anti-
PA followed by 10 nm protein A gold. 
Labeling is evident on the plasma membrane (E, PM) and in putative early endosomal structures (F), recognized by the presence of a characteristic 
patch of coat material (asterisks). At later times (G–J) labeling is evident within a subset of multivesicular endosomal structures with enrichment 
on internal vesicles (arrowheads). Bars, 200 nm.
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made use of the ldlF cell line, which contains a temperature-
sensitive defect in the 
 
ε
 
 COPI coatomer subunit (
 
ε
 
-COP),
so that 
 
ε
 
-COP is rapidly degraded at the restrictive tempera-
ture (40
 

 
C). Then the generation of ECV/MVBs and trans-
port to late endosomes is inhibited (Whitney et al., 1995)
but bulk internalization and recycling remain normal (Daro
et al., 1997; Gu et al., 1997). As expected, internalization of
PA still occurred in ldlF cells (40
 

 
C). MEK1 was protected
from LF, not for the anticipated reasons, but due to the lack
of conversion to SDS-resistant form of PA
 
heptamer
 
 (Fig. 1 D),
which did occur in wild-type cells grown at 40
 

 
C (not de-
picted). The lack of SDS-resistant form is not due to an
acidification defect, because early endosomes acidify nor-
mally in ldlF cells at 40
 

 
C (Daro et al., 1997; Gu et al.,
1997; Piguet et al., 1999). There is however a plausible ex-
planation. When lacking 
 
ε
 
-COP (40
 

 
C), ldlF early endo-
somes are dramatically altered, appearing like clusters of thin
tubules devoid of vesicular/multivesicular regions (Gu et al.,
1997). Hence, it is attractive to speculate that such regions
are required for PA
 
heptamer
 
 membrane insertion.
Therefore, we analyzed PA-treated cells by electron mi-
croscopy. Specific labeling was initially observed on the PM
(Fig. 1 E) but, after warming the cells to 37
 

 
C, labeling was
increasingly found on the intraluminal vesicles of a subset of
multivesicular endosomes (Fig. 1, G–J, arrowheads). Inter-
estingly, at intermediate times, a consistent observation was
labeling in the region of the coat patch (Fig. 1 F; not de-
picted) implicated in sorting of receptors into multivesicular
endosomes (Sachse et al., 2002).
To further address whether cytoplasmic release of LF re-
quired delivery to late endosomes, we inhibited microtu-
bule-dependent transport using the depolymerizing agent
nocodazole. LF-dependent MEK1 cleavage was delayed, with-
out affecting the formation of SDS-resistant PA
 
heptamer
 
(Fig. 2 A, note that degradation was inhibited as expected
because access to late endosomes and lysosomes is impaired).
To rule out the possibility that this delay was somehow
linked to the presence of some MEK1 on late endosomes
(Wunderlich et al., 2001), we also followed LF-induced
cleavage of another MAPKK, MKK3, which is involved in
the p38 MAPK signaling cascade, different from the MEK1-
dependent ERK pathway. As for MEK1, MKK3 cleavage
was delayed in nocodazole-treated cells (Fig. 2 B). Interest-
ingly, the kinetics of cleavage of MKK3 were slower than
those of MEK1 (Fig. 2 C).
Next, we investigated the effects of nocodazole on MAPKK
cleavage kinetics in macrophages, considered as one of the
important targets of the anthrax lethal toxin (Collier and
Young, 2003). LF-induced MEK1 cleavage, and to a lesser
but reproducible extent MKK3 cleavage, were delayed when
RAW 264 macrophages were treated with nocodazole (Fig.
2 D) indicating that the requirement for transport of LF to
Figure 2. Efficient encounter between LF and its 
target occurs from late endosomes. (A) CHO cells 
were incubated or not with 10 M nocodazole for 
2 h at 37C (nocodazole was then present through-
out the entire experiment), followed by 1 h at 4C 
with 500 ng/ml PAn and 20 ng/ml LF, transferred 
to 37C for different periods of time (in min) in a 
toxin-free medium. 40 g of PNS was analyzed by 
Western blotting against PA, the NH2 terminus of 
MEK1 (N) and LF. The amount of intact MEK1 (A) 
and MKK3 (B) was quantified by densitometry and 
normalized to the amount at time t  0 (n  4, 
errors bars represent SDs). (C) The kinetics of de-
crease in intact MEK1 were compared with that 
of decrease in MKK3. Western blots (inset) were 
quantified by densitometry as in A and B. (D) RAW 
264 macrophages were incubated or not with 10 
M nocodazole (2 h at 37C), followed by 1 h at 
4C with 500 ng/ml PAn and 100 ng/ml LF. 40 g 
of PNS was analyzed by Western blotting against 
the NH2 termini of MEK1 and MKK3. (E) HeLa cells 
were transfected or not with dominant-negative 
rab7N125I cDNA, incubated at 4C for 1 h with 
500 ng/ml PAn and 500 ng/ml LF and transferred 
to 37C for different periods of time (in min) in a 
toxin-free medium. 40 g of PNS was analyzed as 
in A (n  4).
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late endosomes is a general feature of anthrax intoxication.
Interestingly, as in CHO cells, kinetics of MKK3 cleavage
were slower than those of MEK1 cleavage.
Because the above observations indicated that LF delivery
preferentially occurs from late endosomes, we decided to af-
fect this organelle by overexpressing a dominant-negative mu-
tant of rab7 (N125I), a small GTPase known to be involved
in late endosome function and dynamics (Gruenberg, 2001).
Although formation (Fig. 2 E) and degradation (not depicted)
of SDS-resistant PA
 
heptamer
 
 occurred normally, cleavage of
MEK1 was again delayed (Fig. 2 E) confirming the involve-
ment of late endosomes in cytoplasmic delivery of LF.
Altogether, the above experiments support the following
sequence of events: the LF–PA
 
heptamer
 
 complex is internal-
ized; in early endosomes, PA
 
heptamer
 
 undergoes membrane
insertion and mediates translocation of LF, in vitro studies
indeed indicate that channel formation by PA is sufficient
to allow translocation of LF. At that stage however, LF
remains associated with early endosomes and microtubule-
dependent transport to late endosomes is required for ef-
ficient delivery to the cytoplasm where LF can reach
MAPKKs. The question arises why translocated LF can
reach the cytoplasm from late endosomes but not from
early endosomes. One possibility is that PA
 
heptamer
 
 preferen-
tially inserts into the membrane of intraluminal vesicles as
suggested by the electron microscopy images (Fig. 1, G–J),
which would lead to translocation of LF into the lumen of
these vesicles.
Sorting into and formation of intraluminal vesicles occurs
in early endosomes and seems to be, at that stage, a one-way
street (Katzmann et al., 2002; Gruenberg and Stenmark,
2004). Once these intraluminal vesicles have reached late
endosomes, some apparently acquire the ability to undergo
regulated back fusion with the limiting membrane. The
membrane of intraluminal vesicles indeed not only contains
proteins destined to be degraded but also proteins in transit
to other destinations in the cell (Kobayashi et al., 2000;
Chow et al., 2002), which must get back to the limiting
membrane from which budding of outgoing vesicles occurs
(Gruenberg, 2001; Murk et al., 2003). To test whether this
localized ability of back fusion of intraluminal vesicles could
be used by LF to reach the cytoplasm, we affected one of
the abundant and important components of intraluminal
vesicles, the unconventional lipid lysobisphosphatidic acid
(LBPA; Gruenberg, 2001). This lipid is unique to late endo-
somes and it was shown that feeding cells with a monoclonal
antibody against LBPA, 6c4, impairs sorting of proteins and
lipids leading to a traffic jam in the compartment (Koba-
yashi et al., 1999). We found that incubating cells with the
6c4 antibody did not affect the kinetics of formation of
SDS-resistant PA
 
heptamer
 
 as expected, but significantly de-
layed cleavage of MEK1 by LF (Fig. 3 A).
To further address the importance of intraluminal vesicles
in LF delivery, we knocked down by RNAi the expression of
ALIX, the mammalian homologue of the yeast class E vacu-
olar protein sorting vps31, involved in multivesicular body
Figure 3. Alteration of the dynamics of late 
endosomal intraluminal vesicles leads to a delay 
in MEK1 cleavage by LF. (A) CHO cells were incu-
bated or not for 18 h with the anti-LBPA antibody 
6c4 (50 g/ml), washed, further incubated at 4C 
for 1 h with 500 ng/ml PAn and 250 ng/ml LF, and 
transferred to 37C for different periods of time (in 
min) in a toxin-free medium. 20 g of PNS was 
analyzed by Western blotting to detect PAheptamer, 
the NH2 terminus of MEK1 and LF. The amount of 
intact MEK1 was quantified as in Fig. 2 A (n  4). 
(B) HeLa cells were transfected with siRNA against 
ALIX, the efficiency of which was examined 78 h 
later by Western blotting using antibodies against 
ALIX. Cells were then incubated at 4C for 1 h 
with 500 ng/ml PAn and 100 ng/ml LF, transferred 
to 37C for different periods of time (in min) in a 
toxin-free medium, homogenized, and 20 g 
of PNS was analyzed to detect the presence of 
PAheptamer and the NH2 terminus of MEK1. Quanti-
fications were performed as in A. (C) HeLa cells 
were treated as in B. 80 g of PNS were centrifuged 
at 100,000 g for 1 h and the pellet analyzed by 
Western blotting for LF. (D) CHO cells were treated 
as in A and incubated with 500 ng/ml PAn and 
500 ng/ml FP59. 20 g of cell lysates were loaded 
on native or SDS-PAGE before Western blotting 
against EF-2. (E) ALIX was knocked down in HeLa 
cells as in B, incubated with 500 ng/ml PAn with 
500 ng/ml FP59, and the modification of EF2 
analyzed as in D.
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sorting and biogenesis (Odorizzi et al., 2003). Interestingly,
ALIX has recently been proposed to directly regulate the dy-
namics of late endosome intraluminal vesicles (Matsuo et
al., 2004). Formation of SDS-resistant PA
 
heptamer
 
, as well as
its degradation, occurred normally in ALIX siRNA-treated
cells (Fig. 3 B). Remarkably however, MEK1 cleavage was
strongly delayed (Fig. 3 B), as was that of MKK3 (not de-
picted). To test whether LF remained trapped in late endo-
somes in ALIX RNAi-treated cells, we separated membrane-
bound organelles from cytosol by high speed centrifugation.
Membrane associated LF decreased with time in control
cells as expected due to its release into the cytoplasm (Fig. 3
C). In contrast, LF remained largely associated with the or-
ganellar fraction in ALIX RNAi-treated cells. Note that
whereas PA
 
heptamer
 
 was normally degraded between 20 and 30
min in ALIX siRNA-treated cells (Fig. 3 B), LF remained in-
tact during that time, in agreement with its proposed local-
ization to the lumen of intraluminal vesicles—topologically
equivalent to the cytoplasmic space—where it would be pro-
tected from lysosomal enzymes.
To rule out that the effects of 6c4 and ALIX siRNA were
somehow related to the metalloprotease activity of LF rather
than the trafficking of the toxin, we used a hybrid (called fu-
sion protein 59; FP59) in which the metalloprotease domain
of LF had been replaced by the ADP-ribosyltransferase do-
main of Pseudomonas exotoxin A, which modifies elonga-
tion factor 2 (EF-2). Because this modification leads to a
change in charge of EF-2 it can be monitored on native gels
(Liu and Leppla, 2003b). Incubation of cells with nocoda-
zole (not depicted), anti-LBPA antibody 6c4, as well as the
knockdown of ALIX, delayed the kinetics of ADP-ribosyla-
tion of EF-2 by FP59 (Fig. 3, D and E).
To exclude that the various treatment had a gross effect on
the endocytic pathway, we repeated the studies using a differ-
ent toxin, namely diphtheria toxin (DT), known to translo-
cate into the cytoplasm at the level of early endosomes (Pa-
pini et al., 1993; Lemichez et al., 1997). DT is also an A-B
toxin, where the A subunit is, as Pseudomonas exotoxin A, an
ADP-ribosyltransferase that modifies EF-2. We first tested
ldlF cells at 40
 

 
C and found that they were insensitive to DT
(Fig. 4 A) because ADP-ribosylation of EF-2 did not occur
(Fig. 4 B). However, in contrast to what was observed for an-
thrax lethal toxin and PA
 

 
FP59, treatment with nocodazole
had no effect on the kinetics of substrate modification by DT
(Fig. 4 C), nor did incubation with the anti-LBPA antibody
6c4 (Fig. 4 D) or RNAi against ALIX (Fig. 4 E).
Based on the present data, we would like to propose the
following models for the modes of delivery of anthrax le-
thal and DTs. Both toxins are internalized via clathrin-
coated pits (Moya et al., 1985; Abrami et al., 2003) and
transported to early endosomes where they are preferen-
tially sorted to the vesicular regions (Fig. 5, A and B) as
suggested by the fact that neither toxin affects lflF cells
(40
 

 
C), which lack vesicular regions in early endosomes
due to degradation of 
 
ε
 
-COP. From that point, the path-
ways of the two toxins diverge. DT remains in the limiting
membrane of early endosomes. Thus, upon membrane in-
sertion, the ADP-ribosyltransferase is directly translocated
from the endosomal lumen to the cytoplasm where it can
reach EF-2 (Fig. 5 B). In contrast, the LF–PA
 
heptamer
 
 com-
plex is sorted into nascent intraluminal vesicles. Thus,
upon PA
 
heptamer
 
-mediated membrane translocation, LF does
not reach the cytoplasm but the lumen of the intraluminal
vesicles (Fig. 5 A). Upon subsequent budding of ECV/
Figure 4. Cytosolic delivery of DT is COPI dependent but does 
not require transport to late endosomes. (A and B) ldlF cells were 
grown at the permissive or restrictive temperature for 16 h, incubated 
for 7 h (A) or 2.5 h (B) at 37C in serum-free medium with 500 ng/ml 
of DT or trypsin-nicked DT (DTn) or left untreated (cont.). (B) Cell 
lysates were prepared and the modification of EF2 analyzed as in 
Fig. 3 D. (C) Wild-type CHO cells were incubated or not with 10 
M nocodazole for 2 h at 37C and 15 min at 4C, followed by 1 h 
at 4C with 500 ng/ml DTn, washed and further incubated for differ-
ent times at 37C. The modification of EF2 was analyzed as above. 
(D) CHO cells were treated with 6c4 antibody as in Fig. 3 A and 
incubated with 500 ng/ml DTn and modification of EF2 analyzed. 
The band labeled with an asterisk is a cross-reacting protein, apparent 
in certain experiments. (E) ALIX was knocked down in HeLa cells 
as in Fig. 3 B, incubated with 500 ng/ml DTn, and modification of 
EF2 analyzed.
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MVB from early endosomes, PA
 
heptamer and LF containing
intraluminal vesicles are transported to late endosomes.
There, PAheptamer is rapidly degraded but this has no conse-
quences because PA has already fulfilled its translocation
function. LF, being in the lumen of the intraluminal vesi-
cles is protected from degradative enzymes and awaits back
fusion events with the limiting membrane to be freed into
the cytoplasm.
There might be a biological rational, aimed at increasing
toxin efficiency, behind the preferential delivery of LF at
the level of late endosomes in the perinuclear region rather
than at the periphery of the cells from early endosomes,
and/or it might have consequences as to the physiological
outcome of the toxins action. As mentioned above, a
MEK1 containing catalytic scaffolding complex, important
for MAPK signaling, was found associated to late endo-
somes (Wunderlich et al., 2001). Similarly other scaffold-
ing domains are likely to localize specifically to the perinu-
clear region of cells. Interestingly, LF-mediated cleavage of
MEK1 was more rapid than that of MKK3 (Fig. 2 C).
Along the same line, LF-induced inhibition of ERK1 acti-
vation, involving MEK1, occurs at fivefold lower LF con-
centrations than p38 inactivation, involving MKK3 (Park
et al., 2002). These examples support the notion that de-
livery of LF from late endosomes in the close proximity of
a target, in this case MEK1, is more efficient than relying
on stochastic encounter with distant targets, in this case
MKK3, by diffusion through the cytoplasm. Target en-
counter by the diffusion is generally assumed for delivered
bacterial toxins, a notion that might have to be revised.
Delivery at a specific site in the cell might be particularly
important at the low toxin concentrations encountered
during the early stages of infection. It is not clear at present
whether one specific MAPKK is a dominant LF target in a
given cell type, nor whether unidentified, non-MAPKK,
LF targets exist. However, it is tempting to speculate that
late endosomes act as encounter platforms between LF and
early targets in the perinuclear region of the cell.
Materials and methods
Cells and reagents
Wild-type PA, PASNKE, LF, FP59, a recombinant fusion toxin consisting
of LF amino acids 1–254, fused to the ADP-ribosylation domain of
Pseudomonas exotoxin A, and DT were produced as described previously
(Liu and Leppla, 2003a, b) and the corresponding polyclonal antibodies
used (Abrami et al., 2003). Antibodies against the COOH terminus of
MEK1 were purchased from Santa Cruz Biotechnology, Inc.; the NH2 ter-
minus of MEK1 was purchased from Upstate Biotechnology; the NH2 ter-
minus of MKK3, EF-2, and rab5 was purchased from Santa Cruz Biotech-
nology Inc.; and rab7, -COP, and LBPA were gifts from J. Gruenberg
(University of Geneva). Antibodies against ALIX were a gift from R. Sadoul
(University of Grenoble, Grenoble, France). Nocodazole was purchased
from Sigma-Aldrich. HeLa, CHO, and mutant ldlF cells (provided by M.
Krieger; Massachusetts Institute of Technology, Cambridge, MA), and
RAW 264 cells were maintained as described previously (Abrami et al.,
1998, 2003). The dominant-negative Rab7 N125I mutant and siRNA
against ALIX (Matsuo et al., 2004) were gifts from P. Boquet (Institut Na-
tional de la Santé et de la Recherche Médicale and University of Nice,
Nice, France) and J. Gruenberg, respectively.
Biochemical methods
Early and late endosomes were isolated using sucrose density gradients
(Kobayashi et al., 1999). For SDS-PAGE analysis, samples were boiled for
5 min. The various subunits and forms of the anthrax toxin and ADP-ribo-
sylation of EF-2 were detected by Western blotting of SDS-PAGE and na-
tive on 4–20% acrylamide gradient gels (Abrami et al., 2003; Liu and
Leppla, 2003b). Transient transfection experiments in HeLa cells were per-
formed 48 h (1 g cDNA/9.6 cm2 plate) or 72 h (200 pmoles siRNA/9.6
cm2 plate) using Fugene (Roche Diagnostics Corporation) and oligo-
fectamine (Invitrogen) transfection reagents, respectively.
Immunofluorescence
CHO cells were incubated with 500 ng/ml PASNKE, submitted to an anti-
body sandwich and incubated at 37C, submitted to an acid wash to re-
move remaining surface-bound PASNKE and fixed with 3% PFA (Abrami et
al., 2003). Images were acquired using a 100 lens on an Axiophot (Carl
Zeiss MicroImaging, Inc.), equipped with a cooled camera (Hamamatsu)
using the Openlab acquisition software.
We thank M. Krieger, P. Boquet, J. Gruenberg, and R. Sadoul for reagents;
D. Hsu for making toxins; and J. Gruenberg, I. Le Blanc, and M. Moayeri
for critical reading of the manuscript.
This work was supported the Swiss National Science Foundation, the
EMBO Young Investigator Program, and the National Institutes of Health
(AI053270-01).
Figure 5. Endocytic routes of anthrax and diph-
theria toxins. Based on the present work and the 
literature, we propose the following models for the 
delivery of anthrax lethal toxin (A) and DT (B) to 
the cytoplasm. Both toxins are internalized, trans-
ported to early endosomes, and sorted into the 
vesicular regions. (A) Anthrax toxin would be sorted 
into intraluminal vesicles whereby membrane 
insertion of PA and translocation of LF would result 
in trapping of the metalloprotease in the lumen of 
intraluminal vesicles. Once transported to late 
endosomes, back fusion of intraluminal vesicles 
with the limiting membrane would deliver LF to 
the cytoplasm. (B) In contrast, in early endosomes, 
DT would preferentially insert into the limiting 
membrane allowing direct delivery to the cytoplasm.
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